Cargando…

Aberrant Methylation of Protocadherin 17 and its Clinical Significance in Patients with Prostate Cancer after Radical Prostatectomy

BACKGROUND: Aberrant methylation of protocadherin 17 (PCDH17) has been reported in several human cancers. However, the methylation status of PCDH17 in prostate cancer and its clinical significance remains unclear. The aim of this study was to investigate the methylation status of PCDH17 and its clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Li, Xie, Pei-Gen, Wang, Li, Ma, Jian-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136940/
https://www.ncbi.nlm.nih.gov/pubmed/25091018
http://dx.doi.org/10.12659/MSM.891247